Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fibroblast Growth Factor Receptor Substrate 2 (FRS2) (Middle Region) Peptid

FRS2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5672209

Kurzübersicht für Fibroblast Growth Factor Receptor Substrate 2 (FRS2) (Middle Region) Peptid (ABIN5672209)

Target

FRS2 (Fibroblast Growth Factor Receptor Substrate 2 (FRS2))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    ANNTEWDTGY DSDERRDAPS VNKLVYENIN GLSIPSASGV RRGRLTSTST

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti- FRS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FRS2 (Fibroblast Growth Factor Receptor Substrate 2 (FRS2))

    Hintergrund

    Adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. Plays an important role in the activation of MAP kinases and in the phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, in response to ligand-mediated activation of FGFR1. Modulates signaling via SHC1 by competing for a common binding site on NTRK1.

    Alias Symbols: SNT, SNT1, FRS1A, FRS2A, SNT-1, FRS2alpha

    Protein Size: 508

    Gen-ID

    10818

    NCBI Accession

    NM_001042555, NP_001036020

    UniProt

    Q8WU20
Sie sind hier:
Chat with us!